心血管指南

订阅

MedSci主页 / 所有栏目 / 心血管指南

2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）

2020-12-17 美国心脏病学会 J Am Coll Cardiol.2021 Feb 2;77(4):450-500.

心脏瓣膜病

2020年12月，美国心脏病学会(ACC)联合美国心脏协会(AHA)共同发布了心脏瓣膜病患者的管理指南。指南主要聚焦心脏瓣膜病患者的诊断和管理，共包括16部分内容。本文为该指南的执行概要内容。

中文标题：

2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）

英文标题：

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary

发布机构：

美国心脏病学会

发布日期：

2020-12-17

简要介绍：

2020年12月，美国心脏病学会(ACC)联合美国心脏协会(AHA)共同发布了心脏瓣膜病患者的管理指南。指南主要聚焦心脏瓣膜病患者的诊断和管理，共包括16部分内容。本文为该指南的执行概要内容。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3ad481c00210ae2b, title=2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）, enTitle=2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary, guiderFrom=J Am Coll Cardiol.2021 Feb 2;77(4):450-500., authorId=0, author=, summary=2020年12月，美国心脏病学会(ACC)联合美国心脏协会(AHA)共同发布了心脏瓣膜病患者的管理指南。指南主要聚焦心脏瓣膜病患者的诊断和管理，共包括16部分内容。本文为该指南的执行概要内容。, cover=https://img.medsci.cn/2021522/1621698093020_2020535.jpg, journalId=0, articlesId=null, associationId=849, associationName=美国心脏病学会, associationIntro=null, copyright=0, guiderPublishedTime=Thu Dec 17 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">2020年12月，美国心脏病学会(ACC)联合美国心脏协会(AHA)共同发布了心脏瓣膜病患者的管理指南。指南主要聚焦心脏瓣膜病患者的诊断和管理，共包括16部分内容。本文为该指南的执行概要内容。</span></p> </div> </div> </div>, tagList=[TagDto(tagId=1639, tagName=心脏瓣膜病)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1639, guiderKeyword=心脏瓣膜病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3544, appHits=354, showAppHits=0, pcHits=895, showPcHits=3190, likes=0, shares=10, comments=11, approvalStatus=1, publishedTime=Sat May 22 23:42:00 CST 2021, publishedTimeString=2020-12-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 22 23:41:41 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:11:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）.pdf)])
2020 ACC_AHA指南：心脏瓣膜病患者的管理（概要）.pdf
下载请点击：
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1078070, encodeId=6a3c10e8070f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:27:33 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069083, encodeId=50a91069083eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpRgudnPLwNOVDmJUY8JRibotSAD6fJyxu2ZeRyGInv2WLGdtiaWc8BnHNibticIBtruwkttbEiciar3icQ/132, createdBy=1f125306024, createdName=wchhaha, createdTime=Wed Nov 10 21:06:52 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002011, encodeId=e353100201138, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Jul 23 14:45:24 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974945, encodeId=02179e4945f9, content=感谢分享，非常实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/277f828b3e95400097d9ca7c7494a124/a09549b6ce524fa9a21419060de8d0d0.jpg, createdBy=e8685466330, createdName=Ashley Zhao, createdTime=Sat Jun 19 19:03:27 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974148, encodeId=03d69e4148b2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e9b5526613, createdName=ms8000000629652319, createdTime=Wed Jun 16 17:59:09 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-12-08 ms6000001082899403

    学习了

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1078070, encodeId=6a3c10e8070f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:27:33 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069083, encodeId=50a91069083eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpRgudnPLwNOVDmJUY8JRibotSAD6fJyxu2ZeRyGInv2WLGdtiaWc8BnHNibticIBtruwkttbEiciar3icQ/132, createdBy=1f125306024, createdName=wchhaha, createdTime=Wed Nov 10 21:06:52 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002011, encodeId=e353100201138, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Jul 23 14:45:24 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974945, encodeId=02179e4945f9, content=感谢分享，非常实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/277f828b3e95400097d9ca7c7494a124/a09549b6ce524fa9a21419060de8d0d0.jpg, createdBy=e8685466330, createdName=Ashley Zhao, createdTime=Sat Jun 19 19:03:27 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974148, encodeId=03d69e4148b2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e9b5526613, createdName=ms8000000629652319, createdTime=Wed Jun 16 17:59:09 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-11-10 wchhaha

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1078070, encodeId=6a3c10e8070f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:27:33 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069083, encodeId=50a91069083eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpRgudnPLwNOVDmJUY8JRibotSAD6fJyxu2ZeRyGInv2WLGdtiaWc8BnHNibticIBtruwkttbEiciar3icQ/132, createdBy=1f125306024, createdName=wchhaha, createdTime=Wed Nov 10 21:06:52 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002011, encodeId=e353100201138, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Jul 23 14:45:24 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974945, encodeId=02179e4945f9, content=感谢分享，非常实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/277f828b3e95400097d9ca7c7494a124/a09549b6ce524fa9a21419060de8d0d0.jpg, createdBy=e8685466330, createdName=Ashley Zhao, createdTime=Sat Jun 19 19:03:27 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974148, encodeId=03d69e4148b2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e9b5526613, createdName=ms8000000629652319, createdTime=Wed Jun 16 17:59:09 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-07-23 Doctoryangbai

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1078070, encodeId=6a3c10e8070f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:27:33 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069083, encodeId=50a91069083eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpRgudnPLwNOVDmJUY8JRibotSAD6fJyxu2ZeRyGInv2WLGdtiaWc8BnHNibticIBtruwkttbEiciar3icQ/132, createdBy=1f125306024, createdName=wchhaha, createdTime=Wed Nov 10 21:06:52 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002011, encodeId=e353100201138, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Jul 23 14:45:24 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974945, encodeId=02179e4945f9, content=感谢分享，非常实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/277f828b3e95400097d9ca7c7494a124/a09549b6ce524fa9a21419060de8d0d0.jpg, createdBy=e8685466330, createdName=Ashley Zhao, createdTime=Sat Jun 19 19:03:27 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974148, encodeId=03d69e4148b2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e9b5526613, createdName=ms8000000629652319, createdTime=Wed Jun 16 17:59:09 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-19 Ashley Zhao

    感谢分享，非常实用！

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1078070, encodeId=6a3c10e8070f2, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bd535418836, createdName=ms6000001082899403, createdTime=Wed Dec 08 11:27:33 CST 2021, time=2021-12-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1069083, encodeId=50a91069083eb, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTIpRgudnPLwNOVDmJUY8JRibotSAD6fJyxu2ZeRyGInv2WLGdtiaWc8BnHNibticIBtruwkttbEiciar3icQ/132, createdBy=1f125306024, createdName=wchhaha, createdTime=Wed Nov 10 21:06:52 CST 2021, time=2021-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1002011, encodeId=e353100201138, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLyXfB3bOYOsDt885AsrYWhiaRtRdPh9aZlXugm7XErBVXusv5fJLIKWTicmjSQcOibDiaLzE2YMD44PA/132, createdBy=49f71976501, createdName=Doctoryangbai, createdTime=Fri Jul 23 14:45:24 CST 2021, time=2021-07-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974945, encodeId=02179e4945f9, content=感谢分享，非常实用！, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210619/277f828b3e95400097d9ca7c7494a124/a09549b6ce524fa9a21419060de8d0d0.jpg, createdBy=e8685466330, createdName=Ashley Zhao, createdTime=Sat Jun 19 19:03:27 CST 2021, time=2021-06-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974148, encodeId=03d69e4148b2, content=感谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e9b5526613, createdName=ms8000000629652319, createdTime=Wed Jun 16 17:59:09 CST 2021, time=2021-06-16, status=1, ipAttribution=)]
    2021-06-16 ms8000000629652319

    感谢分享

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

中国成人心脏瓣膜病超声心动图规范化检查专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2021-02-20

2020 ACC/AHA指南：心脏瓣膜病患者的管理

美国心脏病学会(ACC,American College of Cardiology) · 2020-12-17

2017年美国心脏病学会/美国心脏协会：心脏瓣膜病患者管理指南更新：要点解读及前景展望

暂未更新 · 2018-02-20

2017年ESC/EACTs与AHA/ACC心脏瓣膜疾病管理的指南解读

暂未更新 · 2017-11-30

2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2017-11-01

【合集】ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

暂未更新 · 2017-03-03

拓展阅读

EAE/ASE 超声心动图在心脏瓣膜病经导管介入治疗新技术中应用的建议

美国超声心动图学会(ASE,American Society of Echocardiography) · 2011-09-01

2014 年美国心脏瓣膜病指南解读

美国心脏协会(AHA,American Heart Association) · 2015-09-30

【合集】ASE及AHA/ACC心脏瓣膜病相关指南中文版翻译合集

暂未更新 · 2017-03-03

2017 EHRA/ESC共识文件：心脏瓣膜病相关性房颤的抗栓治疗

欧洲心律学会(EHRA,European Heart Rhythm Association) · 2017-11-01

2017年ESC/EACTs与AHA/ACC心脏瓣膜疾病管理的指南解读

暂未更新 · 2017-11-30

2017年美国心脏病学会/美国心脏协会：心脏瓣膜病患者管理指南更新：要点解读及前景展望

暂未更新 · 2018-02-20